OsteoporeASX:OSX +12.50% Days Payable is 703.65 as of Dec. 2025, which is 3% below its 10-year median of 722.72. The stock has 7 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Osteopore ranks better than 93.08% on this metric.
Osteopore's average Accounts Payable for the
six
months ended in Dec. 2025 was A$1.24 Mil. Osteopore's Cost of Goods Sold for the
six
months ended in Dec. 2025 was A$0.32 Mil.
Hence, Osteopore's Days Payable for the
six
months ended in Dec. 2025 was 703.65.
The historical rank and industry rank for Osteopore's Days Payable or its related term are showing as below:
ASX:OSX'
s Days Payable Range Over the Past 10 Years
Min: 315.89 Med: 722.72 Max: 1170.03
Current: 553.51
During the past 8 years, Osteopore's highest Days Payable was 1170.03. The lowest was 315.89. And the median was 722.72.
ASX:OSX's Days Payable is ranked better than 93.08% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs ASX:OSX: 553.51
Osteopore's Days Payable
declined
from Dec. 2024 (801.93) to Dec. 2025 (703.65).
It may suggest that Osteoporeaccelerated paying its suppliers.
Osteopore Days Payable Related Terms
Osteopore Days Payable Historical Data
* Premium members only.
The historical data trend for Osteopore's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:OSX vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Osteopore's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Osteopore Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Osteopore's Days Payable distribution charts can be found below:
* The bar in red indicates where Osteopore's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Osteopore's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Osteopore (ASX:OSX) has a Days Payable of 703.65 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Osteopore and its competitors. This is near median its historical median of 722.72. Over the past decade, Osteopore's Days Payable has ranged from 315.89 to 1,170.03. According to the industry distribution chart, Osteopore ranks #55 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 6.9%.
Is Osteopore's Days Payable too high?
Osteopore's current Days Payable of 703.65 is near median its 10-year median of 722.72. Over the past 10 years, this metric has ranged from a low of 315.89 to a high of 1,170.03. The Medical Devices & Instruments industry median Days Payable is 67.87. Osteopore's value of 703.65 is 936.8% above this industry median. Based on the distribution chart, Osteopore ranks #55 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers.
How does Osteopore's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Osteopore ranks #55 out of 795 companies for Days Payable. This places Osteopore in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Osteopore's value of 703.65 is 936.8% above this benchmark. Historically, Osteopore's own Days Payable has ranged from 315.89 to 1,170.03 over the past decade. While the company's 10-year median is 722.72 vs. the industry median of 67.87, Osteopore has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Osteopore's current Days Payable of 703.65 is 936.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Osteopore and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Osteopore's current Days Payable is 703.65, which is near median its own 10-year median of 722.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osteopore stock overvalued right now?
Based on GuruFocus' analysis, Osteopore (ASX:OSX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.00 — trading 77.5% below its estimated fair value. The current Days Payable is 703.65, which is near median its 10-year median of 722.72 and 936.8% above the Medical Devices & Instruments industry median of 67.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Osteopore (ASX:OSX), the current Days Payable is 703.65 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. It operate in the high-growth regenerative medicine sector, where adoption continues to rise as healthcare systems increasingly embrace developed tissue-regenerative solutions. Business operating segments are based on the firm's geographical presence in Singapore and Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:OSX has been successfully added to your 